(Q46494654)
English
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial
scientific article published in April 1990
- Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled Trial
Statements
1 reference
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial (English)
1 reference
Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled Trial (English)
0 references
JÜRGEN MARGRAF
1 reference
ANKE EHLERS
Ehlers A
1 reference
Taylor CB
1 reference
Hayward C
1 reference
King R
1 reference
Maddock R
1 reference
Clark D
1 reference
Roth WT
1 reference
Agras WS
1 reference
1 April 1990
1 reference
April 1990
0 references
10
1 reference
2
1 reference
112-118
1 reference